Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚น45.70 B
Marketcap
โ‚น125.77
Share price
-1.41%
Change (1 day)
128.49%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น10.41 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has โ‚น10.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น20.41 B44.22%
2023-12-31โ‚น14.15 B23.63%
2022-12-31โ‚น11.44 B77.33%
2021-12-31โ‚น6.45 B-42.02%
2020-12-31โ‚น11.13 B-42.51%
2019-12-31โ‚น19.37 B73.1%
2018-12-31โ‚น11.19 B-43.6%
2017-12-31โ‚น19.84 B-15.72%
2016-12-31โ‚น23.54 B-32.04%
2015-12-31โ‚น34.64 B61.1%
2014-12-31โ‚น21.50 B169.59%
2013-12-31โ‚น7.97 B-34.72%
2012-12-31โ‚น12.22 B-17.99%
2011-12-31โ‚น14.90 B57.52%
2010-12-31โ‚น9.45 B25.45%
2009-12-31โ‚น7.54 B52.15%
2008-12-31โ‚น4.95 B-51.2%
2007-12-31โ‚น10.15 B186.63%
2006-12-31โ‚น3.54 B-21.02%
2005-12-31โ‚น4.48 B18.31%
2004-12-31โ‚น3.79 B-19.95%
2003-12-31โ‚น4.73 B5.52%
2002-12-31โ‚น4.48 B-37.87%
2001-12-31โ‚น7.22 B-23.61%
2000-12-31โ‚น9.45 B2276.26%
1999-12-31โ‚น0.39 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.27 B-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น758.54 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น38.20 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น132.76 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น318.55 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น8.30 B-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น114.81 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น60.81 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น15.49 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA